Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Blood
|
April 12, 2015
Myeloma cell-derived Runx2 promotes myeloma progression in bone
Timothy N Trotter, Mei Li, Qianying Pan, et al.
American Journal of Clinical Pathology
|
March 8, 2023
T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases
Zhihong Hu, L Jeffrey Medeiros, Mina Xu, et al.
Annals of Diagnostic Pathology
|
August 28, 2023
Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature
Zhiyan Fu, Haibo Wang, Gregory Y Lauwers, et al.
Leukemia
|
October 21, 2021
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome
Peng Li, Thomas White, Wei Xie, et al.
Acta Haematologica
|
November 22, 2014
A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution
Deniz Peker, Eric Padron, John M Bennett, et al.
Blood
|
June 7, 2022
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms
Peng Li, Sara Brown, Margaret Williams, et al.
American Journal of Clinical Pathology
|
October 13, 2021
Hantavirus Disease and COVID-19
Allison K Joyce, Tarrah T Oliver, Aaron D Kofman, et al.
Archives of Pathology & Laboratory Medicine
|
April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus
Alejandro A Gru, Megan S Lim, Ahmet Dogan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2023
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group
Daniel Rivera, Wei Cui, Juehua Gao, et al.
American Journal of Hematology
|
November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies
Luciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Blood
|
April 12, 2015
Myeloma cell-derived Runx2 promotes myeloma progression in bone
Timothy N Trotter, Mei Li, Qianying Pan, et al.
American Journal of Clinical Pathology
|
March 8, 2023
T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases
Zhihong Hu, L Jeffrey Medeiros, Mina Xu, et al.
Annals of Diagnostic Pathology
|
August 28, 2023
Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature
Zhiyan Fu, Haibo Wang, Gregory Y Lauwers, et al.
Leukemia
|
October 21, 2021
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome
Peng Li, Thomas White, Wei Xie, et al.
Acta Haematologica
|
November 22, 2014
A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution
Deniz Peker, Eric Padron, John M Bennett, et al.
Blood
|
June 7, 2022
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms
Peng Li, Sara Brown, Margaret Williams, et al.
American Journal of Clinical Pathology
|
October 13, 2021
Hantavirus Disease and COVID-19
Allison K Joyce, Tarrah T Oliver, Aaron D Kofman, et al.
Archives of Pathology & Laboratory Medicine
|
April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus
Alejandro A Gru, Megan S Lim, Ahmet Dogan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2023
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group
Daniel Rivera, Wei Cui, Juehua Gao, et al.
American Journal of Hematology
|
November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies
Luciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
Page
of 5